111, Inc. YI
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $1.80B, -9.0% YoY · Filed Apr 30, 2026
111, Inc. (YI) files with the SEC under industry code 5912, Retail-Drug Stores and Proprietary Stores. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.8 billion and a net loss of $3.2 million. Free cash flow was $16.4 million. As of Dec 31, 2025 it held $80.2 million in cash and investments and $31.1 million in total debt.
Revenue
$1.80B
-9.0% vs prior year
Net income
$-3.22M
-13.1% vs prior year
Operating cash flow
$17.04M
-52.7% vs prior year
Free cash flow
$16.40M
-51.7% vs prior year
EPS
$-0.05
+0.0% vs prior year
Dividend per share
None
Shares outstanding
—
Net cash
$49.10M
FY 2025
Operating margin
-0.0%
FY 2025
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- YI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Shanghai
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1738906
Other Retail-Drug Stores and Proprietary Stores companies
- CVS HEALTH Corp CVS
- Guardian Pharmacy Services, Inc. GRDN
- Petmed Express Inc PETS
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.8B | $2.0B | $2.1B | $2.0B | $1.9B |
| Operating income | -$340,000 | $289,000 | -$49.3M | -$53.8M | -$100.8M |
| Net income | -$3.2M | -$2.8M | -$49.8M | -$54.5M | -$97.5M |
| Diluted EPS | -$0.05 | -$0.05 | -$0.33 | -$0.36 | -$0.63 |
| Operating cash flow | $17.0M | $36.0M | -$63.0M | -$3.4M | -$108.1M |
| Free cash flow | $16.4M | $34.0M | -$64.4M | -$7.9M | -$117.9M |
| Total assets | $314.6M | $381.9M | $435.1M | $503.7M | $493.6M |
| Total liabilities | $284.0M | $329.8M | $396.2M | $409.7M | $360.5M |
| Stockholders' equity | -$100.4M | -$88.0M | -$82.2M | -$60.1M | -$27.2M |
| Cash and investments | $80.2M | $63.3M | $92.3M | $127.8M | $132.9M |
| Total debt | $31.1M | $29.6M | $56.4M | $40.5M | $66.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Sep 28, 2026 | Sep 28, 2026 |
| 6-K | Current report (foreign issuer) | Sep 17, 2026 | Sep 17, 2026 |
| 6-K | Current report (foreign issuer) | Sep 17, 2026 | Sep 17, 2026 |
| 6-K | Current report (foreign issuer) | Jun 4, 2026 | Jun 4, 2026 |
| 20-F | Annual report (foreign issuer) | Apr 30, 2026 | Dec 31, 2025 |
Source: SEC EDGAR filings. This is company-reported data, not investment advice.